ロード中...
Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy
Ospemifene—a third-generation selective estrogen receptor modulator approved by the Food and Drug Administration in 2013—is an oral medication for the treatment of dyspareunia. In postmenopausal women with vulvovaginal atrophy, ospemifene significantly improves the structure and pH levels of the vag...
保存先:
| 出版年: | J Menopausal Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Society of Menopause
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606913/ https://ncbi.nlm.nih.gov/pubmed/28951854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6118/jmm.2017.23.2.79 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|